Literature DB >> 33398872

Extracellular vesicles derived from mesenchymal stem cells: A platform that can be engineered.

Bo Qin1, Qi Zhang2, Dan Chen2, Hai-Yang Yu2, Ai-Xiang Luo2, Liang-Peng Suo2, Yan Cai3, De-Yang Cai2, Jia Luo2, Ju-Fang Huang2,4, Kun Xiong2,5.   

Abstract

Mesenchymal stem cells play an important role in tissue damage and repair. This role is mainly due to a paracrine mechanism, and extracellular vesicles (EVs) are an important part of the paracrine function. EVs play a vital role in many aspects of cell homeostasis, physiology, and pathology, and EVs can be used as clinical biomarkers, vaccines, or drug delivery vehicles. A large number of studies have shown that EVs derived from mesenchymal stem cells (MSC-EVs) play an important role in the treatment of various diseases. However, the problems of low production, low retention rate, and poor targeting of MSC-EVs are obstacles to current clinical applications. The engineering transformation of MSC-EVs can make up for those shortcomings, thereby improving treatment efficiency. This review summarizes the latest research progress of MSC-EV direct and indirect engineering transformation from the aspects of improving MSC-EV retention rate, yield, targeting, and MSC-EV visualization research, and proposes some feasible MSC-EV engineering methods of transformation.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33398872     DOI: 10.14670/HH-18-297

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  168 in total

1.  Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model.

Authors:  Suyan Bian; Liping Zhang; Liufa Duan; Xi Wang; Ying Min; Hepeng Yu
Journal:  J Mol Med (Berl)       Date:  2013-12-14       Impact factor: 4.599

Review 2.  Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics.

Authors:  James P K Armstrong; Margaret N Holme; Molly M Stevens
Journal:  ACS Nano       Date:  2017-01-09       Impact factor: 15.881

3.  In Vivo Neuroimaging of Exosomes Using Gold Nanoparticles.

Authors:  Oshra Betzer; Nisim Perets; Ariel Angel; Menachem Motiei; Tamar Sadan; Gal Yadid; Daniel Offen; Rachela Popovtzer
Journal:  ACS Nano       Date:  2017-10-05       Impact factor: 15.881

4.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.

Authors:  Lydia Alvarez-Erviti; Yiqi Seow; Haifang Yin; Corinne Betts; Samira Lakhal; Matthew J A Wood
Journal:  Nat Biotechnol       Date:  2011-03-20       Impact factor: 54.908

5.  Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia.

Authors:  U Altanerova; M Babincova; P Babinec; K Benejova; J Jakubechova; V Altanerova; M Zduriencikova; V Repiska; C Altaner
Journal:  Int J Nanomedicine       Date:  2017-10-27

6.  Exosomes From Human Cardiac Progenitor Cells for Therapeutic Applications: Development of a GMP-Grade Manufacturing Method.

Authors:  Gabriella Andriolo; Elena Provasi; Viviana Lo Cicero; Andrea Brambilla; Sabrina Soncin; Tiziano Torre; Giuseppina Milano; Vanessa Biemmi; Giuseppe Vassalli; Lucia Turchetto; Lucio Barile; Marina Radrizzani
Journal:  Front Physiol       Date:  2018-08-24       Impact factor: 4.566

7.  Biodistribution of gadolinium- and near infrared-labeled human umbilical cord mesenchymal stromal cell-derived exosomes in tumor bearing mice.

Authors:  Javier Abello; Tuyen Duong Thanh Nguyen; Ramesh Marasini; Santosh Aryal; Mark Louis Weiss
Journal:  Theranostics       Date:  2019-04-12       Impact factor: 11.556

Review 8.  Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery.

Authors:  Sophia G Antimisiaris; Spyridon Mourtas; Antonia Marazioti
Journal:  Pharmaceutics       Date:  2018-11-06       Impact factor: 6.321

Review 9.  Mesenchymal Stem Cell-Derived Extracellular Vesicles as Therapeutics and as a Drug Delivery Platform.

Authors:  Gyuhyeon Baek; Hojun Choi; Youngeun Kim; Hai-Chon Lee; Chulhee Choi
Journal:  Stem Cells Transl Med       Date:  2019-05-02       Impact factor: 6.940

Review 10.  Strategic design of extracellular vesicle drug delivery systems.

Authors:  James P K Armstrong; Molly M Stevens
Journal:  Adv Drug Deliv Rev       Date:  2018-06-28       Impact factor: 15.470

View more
  2 in total

Review 1.  Targeting Programmed Cell Death to Improve Stem Cell Therapy: Implications for Treating Diabetes and Diabetes-Related Diseases.

Authors:  Qi Zhang; Xin-Xing Wan; Xi-Min Hu; Wen-Juan Zhao; Xiao-Xia Ban; Yan-Xia Huang; Wei-Tao Yan; Kun Xiong
Journal:  Front Cell Dev Biol       Date:  2021-12-16

Review 2.  Mesenchymal Stem Cell-Derived Extracellular Vesicle: A Promising Alternative Therapy for Osteoporosis.

Authors:  Cheng-Hsiu Lu; Yi-An Chen; Chien-Chih Ke; Ren-Shyan Liu
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.